Received on 28-04-2014 Accepted on 20-05-2014 Aims: There are controversies regarding the proconvulsant effect of first and second generation antihistamines. To compare the seizure potentiating effect of first generation antihistamine cyroheptadine with second generation fexofenadine in animal models of epilepsy. Methods: Thirty rats were used. In bothMES and PTZ model, rats were divides into three groups(n=6). Group I to III received sodium alproate, sodium valproate + cyproheptadine and sodium valproate + fexofenadine respectively in both the models. In MES model 30 minutes after drug administration seizures were induced. Duration of seizures, recovery period and hindlimb extension were recorded. I...
Mohammed A ZolalyDepartment of Pediatrics, College of Medicine, Taibah University, Al-Madinah Al-Mun...
This study aimed to carry out a comparative study of the main models of chronic epilepsy induced by ...
BACKGROUND: The research on the improvement of epilepsy therapy is constantly growing. Valproyl-L...
International audienceRATIONALE: Antiepileptic drugs (AEDs) have been available for many years; yet,...
Background: Presently available antiepileptic drugs are effective in controlling seizures in more th...
Background: Antiepileptic potential of statins, COX inhibitors and other herbal medications are to b...
A newly developed series of non-imidazole histamine H3 receptor (H3R) antagonists (1⁻16) was e...
Nowadays, there are various animal models of acute and chronic seizures. Some chemical and electrica...
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that is commonly used as an anti-inflamm...
Objective: To study the effectiveness and tolerability of antiepileptic drugs (AEDs) commonly used i...
Background: Current antiepileptic drugs (AEDs) are effective in controlling seizures in about 70% pa...
Background: The currently available antiepileptic drugs have a low therapeutic index, and provide sa...
C1 - Journal Articles RefereedPURPOSE: Controlled-release formulations of Valproate (VPA) reduce sid...
AbstractAnimal models for seizures and epilepsy have played a fundamental role in advancing our unde...
WOS: 000461404200005PubMed ID: 30610970Background: Millions of individuals worldwide suffer from epi...
Mohammed A ZolalyDepartment of Pediatrics, College of Medicine, Taibah University, Al-Madinah Al-Mun...
This study aimed to carry out a comparative study of the main models of chronic epilepsy induced by ...
BACKGROUND: The research on the improvement of epilepsy therapy is constantly growing. Valproyl-L...
International audienceRATIONALE: Antiepileptic drugs (AEDs) have been available for many years; yet,...
Background: Presently available antiepileptic drugs are effective in controlling seizures in more th...
Background: Antiepileptic potential of statins, COX inhibitors and other herbal medications are to b...
A newly developed series of non-imidazole histamine H3 receptor (H3R) antagonists (1⁻16) was e...
Nowadays, there are various animal models of acute and chronic seizures. Some chemical and electrica...
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that is commonly used as an anti-inflamm...
Objective: To study the effectiveness and tolerability of antiepileptic drugs (AEDs) commonly used i...
Background: Current antiepileptic drugs (AEDs) are effective in controlling seizures in about 70% pa...
Background: The currently available antiepileptic drugs have a low therapeutic index, and provide sa...
C1 - Journal Articles RefereedPURPOSE: Controlled-release formulations of Valproate (VPA) reduce sid...
AbstractAnimal models for seizures and epilepsy have played a fundamental role in advancing our unde...
WOS: 000461404200005PubMed ID: 30610970Background: Millions of individuals worldwide suffer from epi...
Mohammed A ZolalyDepartment of Pediatrics, College of Medicine, Taibah University, Al-Madinah Al-Mun...
This study aimed to carry out a comparative study of the main models of chronic epilepsy induced by ...
BACKGROUND: The research on the improvement of epilepsy therapy is constantly growing. Valproyl-L...